Market Research Logo

Global Tuberculosis (TB) Diagnostics Market 2017-2021

Global Tuberculosis (TB) Diagnostics Market 2017-2021

About Tuberculosis (TB) Diagnostics

TB is a contagious infection that usually attacks the lungs. It may also spread to other parts of the body such as the brain and the spine. TB commonly spreads through the air when an infected person coughs, sneezes, spits, laughs, or talks. Mycobacterium tuberculosis is responsible for the onset of the disease. In the 20th century, TB was a leading cause of death. However, today, most cases are cured with antibiotics, which is a time-consuming process. Medicines should be taken for at least six to nine months.

Technavio’s analysts forecast the global tuberculosis (TB) diagnostics market to grow at a CAGR of 3.56% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global tuberculosis (TB) diagnostics market for 2017-2021. To calculate the market size, the report considers the new installations, shipments, sales, volume, and value.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Tuberculosis (TB) Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott
  • BD
  • bioMérieux
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
Other prominent vendors
  • Akonni Biosystems
  • Ameritek USA
  • Autobio Diagnostics
  • Cepheid
  • EIKEN CHEMICAL
  • GeTein BioMedical
  • Hain Lifescience
  • Hologic
  • NanoEnTek
  • Ortho Clinical Diagnostics
  • QIAGEN
  • Siemens Healthineers
Market driver
  • Increasing prevalence of TB
  • For a full, detailed list, view our report
Market challenge
  • Accessibility and cost constraints of advanced TB diagnostics
  • For a full, detailed list, view our report
Market trend
  • Expansion of healthcare infrastructure
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Tuberculosis (TB) Diagnostics Market 2017-2021

Technavio recognizes the following companies as the key players in the global tuberculosis (TB) diagnostics market: Abbott, BD, bioMérieux, F. Hoffmann-La Roche, and Thermo Fisher Scientific

Other Prominent Vendors in the market are: Akonni Biosystems, Ameritek USA, Autobio Diagnostics, Cepheid, EIKEN CHEMICAL, GeTein BioMedical, Hain Lifescience, Hologic, NanoEnTek, Ortho Clinical Diagnostics, QIAGEN, and Siemens Healthineers.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Expansion of healthcare infrastructure. Healthcare infrastructure has constantly been expanding across the world. Efforts have also been made to make diagnostic facilities available in rural areas. People are encouraged to visit clinics or healthcare facilities in the vicinity to diagnose and treat diseases. This could reduce the burden of large test volumes from large hospitals. It would also reduce the burden of healthcare expenses rural and semi-urban populations. This is because out of pocket expense would decrease.”

According to the report, one of the major drivers for this market is Increasing prevalence of TB. TB affects a significant proportion of the population each year. In 2015, it was one of the 10 major causes of death, ranking above acquired immunodeficiency syndrome (AIDS). However, TB can be cured through early diagnosis and treatment.

Further, the report states that one of the major factors hindering the growth of this market is Accessibility and cost constraints of advanced TB diagnostics. New and improved diagnostics can reform TB diagnostics. However, it is important to make them accessible in clinics when patients initially seek medical attention for TB. For instance, despite its various features, Xpert was not considered as a POC test. It requires controlled environmental temperatures and continuous power supply, which are not generally accessible in the primary healthcare centers of low‑income countries. It is indicated that the full advantage of enhanced diagnostic tests can only be felt if they are actualized as POC tests. Hence, new diagnostic tests must be designed for low‑income countries. The equipment, skills, and environmental controls in peripheral laboratories are often limited.

Companies Mentioned

Abbott, BD, bioMérieux, F. Hoffmann-La Roche, Thermo Fisher Scientific, Akonni Biosystems, Ameritek USA, Autobio Diagnostics, Cepheid, EIKEN CHEMICAL, GeTein BioMedical, Hain Lifescience, Hologic, NanoEnTek, Ortho Clinical Diagnostics, QIAGEN, and Siemens Healthineers.

  • Executive summary
  • Scope of the report
  • Research methodology
  • Introduction
    • Overview
  • Market landscape
    • Overview
      • Table Share of global TB diagnostics market of global IVD market 2016 (%)
    • Market size and forecast
      • Table Global TB diagnostics market 2016-2021 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Segmentation by product type
    • Overview
      • Table Global TB diagnostics market: Segmentation by product type 2016 (% share)
    • Culture
    • Mantoux tuberculin test
    • Molecular testing
    • Smear microscopy
    • LF-LAM for PLHIV
    • Drug susceptibility testing
  • Segmentation by end-user
    • Overview
      • Table Global TB diagnostics market: Segmentation by end-user 2016 (% share)
    • Hospitals
      • Table Global TB diagnostics market by hospitals 2016-2021 ($ billions)
      • Table Global TB diagnostics market by hospitals: Year-over-year growth 2017-2021 (%)
    • Diagnostic laboratories
      • Table Global TB diagnostic market by diagnostic laboratories 2016-2021 ($ billions)
      • Table Global TB diagnostics market by diagnostic laboratories: Year-over-year growth 2017-2021 (%)
  • Segmentation by geography
    • Overview
      • Table Global TB diagnostics market: Segmentation by geography 2016-2021 (% share)
    • Regional comparison
      • Table Global TB diagnostics market: Regional comparison
    • APAC
      • Table TB diagnostics market in APAC: Overview
      • Table TB diagnostics market in APAC 2016-2021 ($ billions)
      • Table TB diagnostics market in APAC: Year-over-year growth 2017-2021 (%)
    • Americas
      • Table TB diagnostics market in Americas: Overview
      • Table TB diagnostics market in Americas 2016-2021 ($ billions)
      • Table TB diagnostics market in Americas: Year-over-year growth 2017-2021 (%)
    • EMEA
      • Table TB diagnostics market in EMEA: Overview
      • Table TB diagnostics market in EMEA 2016-2021 ($ billions)
      • Table TB diagnostics market in EMEA: Year-over-year growth 2017-2021 (%)
    • Key leading countries
      • Table Global TB diagnostics market: Key leading countries
    • Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Focus on partnerships and acquisitions for product development
    • Continuous technological advances
    • Expansion of healthcare infrastructure
  • Vendor landscape
    • Competitive landscape
      • Table Global TB diagnostics market: Competitive structure analysis 2016
  • Key vendor analysis
    • Abbott
      • Table Abbott: Key highlights
      • Table Abbott: Strength assessment
      • Table Abbott: Strategy assessment
      • Table Abbott: Opportunity assessment
    • BD
      • Table BD: Key highlights
      • Table BD: Strength assessment
      • Table BD: Strategy assessment
      • Table BD: Opportunity assessment
    • bioMérieux
      • Table bioMérieux: Key highlights
      • Table bioMérieux: Strength assessment
      • Table bioMérieux: Strategy assessment
      • Table bioMérieux: Opportunity assessment
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche: Key highlights
      • Table F. Hoffmann-La Roche: Strength assessment
      • Table F. Hoffmann-La Roche: Strategy assessment
      • Table F. Hoffmann-La Roche: Opportunity assessment
    • Thermo Fisher Scientific
      • Table Thermo Fisher Scientific: Key highlights
      • Table Thermo Fisher Scientific: Strength assessment
      • Table Thermo Fisher Scientific: Strategy assessment
      • Table Thermo Fisher Scientific: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report